Early Intensive Glycemic Control for T2D Reduces Longterm Risk for Mortality and Myocardial Infarction
1. Sulfonylurea, insulin therapy, and metformin resulted in a significant relative risk reduction...
Read MoreAug 16, 2024
1. Sulfonylurea, insulin therapy, and metformin resulted in a significant relative risk reduction...
Read MoreAug 16, 2024
1. In patients with an established history of atherosclerotic cardiovascular disease (ASCVD)...
Read MoreAug 15, 2024
1. In this follow-up analysis of a cohort of patients from the RECOVER study, there was no...
Read MoreAug 15, 2024
1. Walking significantly reduced low-back pain recurrence compared to the control group. 2....
Read MoreAug 15, 2024
1. Perturbation-based balance training only showed moderate physical benefits in the short term...
Read MoreAug 13, 2024
1. When comparing corticosteroid peak dose for immunosuppression for anti–PD-1 plus...
Read MoreAug 9, 2024
1. Preschool-aged children in the top tertile of unprocessed food (UPF) consumption had...
Read MoreAug 9, 2024
1. Fewer anti-VEGF intravitreal injections were required in the SRT group over 2 years. 2. Change...
Read MoreAug 8, 2024
1. Incidence of recurrent ischemic stroke, myocardial infarction, cardiac arrest, and...
Read MoreAug 6, 2024
1. Median overall survival was 41 months in the TKI-only group vs 40 months in the TKI-SRS group,...
Read MoreAug 3, 2024
1. Patients who underwent burr-hole drainage with subdural irrigation had fewer reoperation rates...
Read MoreAug 2, 2024
1. Overground Robot-assisted gait training (RAGT), using a new torque-assisted wearable...
Read MoreJul 31, 2024
1. Patients in the sintilimab group reported a significantly greater event-free survival at 36...
Read MoreJul 31, 2024
1. Patient data from a Taiwanese national database demonstrated that those who took...
Read MoreJul 30, 2024
1. In this randomized controlled trial, a prophylactic weekly dose of efanesoctocog alfa...
Read MoreJul 30, 2024
1. Six-year follow-up data reveal that ME/CFS patients treated with cyclophosphamide reported...
Read MoreJul 29, 2024
1. In a retrospective cohort study of women newly diagnosed with breast cancer, use of hormone...
Read MoreJul 28, 2024
1. In this cohort study, majority of the participants did not use all of the opioids prescribed to...
Read MoreJul 26, 2024
1. Tumor response rate at 25 weeks was significantly greater in vimseltinib than placebo. 2. Most...
Read MoreJul 25, 2024
1. Return to baseline function was comparable in tenecteplase and standard-of-care groups. 2. More...
Read More